{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:15:18Z","timestamp":1790716518537,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T00:00:00Z","timestamp":1481500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T00:00:00Z","timestamp":1481500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Antidepressants, prescribed as first line treatment of neuropathic pain, have a limited efficacy and poorly tolerated side effects. Because recent studies pointed out the implication of astroglial connexins (Cx) in both neuropathic pain and antidepressive treatment, we investigated whether their blockade by mefloquine could modulate the action of the tricyclic antidepressant amitriptyline. Using primary cultures, we found that both mefloquine and amitriptyline inhibited Cx43-containing gap junctions, and that the drug combination acted synergically. We then investigated whether mefloquine could enhance amitriptyline efficacy in a preclinical model of neuropathic pain. Sprague-Dawley rats that underwent chronic unilateral constriction injury (CCI) to the sciatic nerve (SN) were treated with either amitriptyline, mefloquine or the combination of both drugs. Whereas acute treatments were ineffective, chronic administration of amitriptyline reduced CCI-SN-induced hyperalgesia-like behavior, and this effect was markedly enhanced by co-administration of mefloquine, which was inactive on its own. No pharmacokinetic interactions between both drugs were observed and CCI-SN-induced neuroinflammatory and glial activation markers remained unaffected by these treatments in dorsal root ganglia and spinal cord.<\/jats:italic>\n                    Mechanisms downstream of CCI-SN-induced neuroinflammation and glial activation might therefore be targeted. Connexin inhibition in astroglia could represent a promising approach towards improving neuropathic pain therapy by antidepressants.\n                  <\/jats:p>","DOI":"10.1038\/srep38766","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T05:32:07Z","timestamp":1481520727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Potentiation of Amitriptyline Anti-Hyperalgesic-Like Action By Astroglial Connexin 43 Inhibition in Neuropathic Rats"],"prefix":"10.1038","volume":"6","author":[{"given":"Tiffany","family":"Jeanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Duch\u00eane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Bourgoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christ\u00e8le","family":"Picoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Ezan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Giaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Charv\u00e9riat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,12]]},"reference":[{"key":"BFsrep38766_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup, N. B. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 14, 162\u2013173 (2015).","journal-title":"Lancet Neurol."},{"key":"BFsrep38766_CR2","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.pain.2011.09.014","volume":"152","author":"N Attal","year":"2011","unstructured":"Attal, N., Lanteri-Minet, M., Laurent, B., Fermanian, J. & Bouhassira, D. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 152, 2836\u20132843 (2011).","journal-title":"Pain"},{"key":"BFsrep38766_CR3","unstructured":"NICE. in Neuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-specialist Settings National Institute for Health and Clinical Excellence: Guidance (2013)."},{"key":"BFsrep38766_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1155\/2014\/754693","volume":"19","author":"D Moulin","year":"2014","unstructured":"Moulin, D. et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag. 19, 328\u2013335 (2014).","journal-title":"Pain Res Manag"},{"key":"BFsrep38766_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/papr.12036","volume":"14","author":"V Piano","year":"2014","unstructured":"Piano, V. et al. Treatment for neuropathic pain in patients with cancer: comparative analysis of recommendations in national clinical practice guidelines from European countries. Pain Pract. 14, 1\u20137 (2014).","journal-title":"Pain Pract"},{"key":"BFsrep38766_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.12703\/P7-56","volume":"7","author":"TL Yaksh","year":"2015","unstructured":"Yaksh, T. L., Woller, S. A., Ramachandran, R. & Sorkin, L. S. The search for novel analgesics: targets and mechanisms. F1000 Prime Rep. 7, 56 (2015).","journal-title":"F1000 Prime Rep"},{"key":"BFsrep38766_CR7","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/glia.22384","volume":"60","author":"MJ Chen","year":"2012","unstructured":"Chen, M. J. et al. Astrocytic CX43 hemichannels and gap junctions play a crucial role in development of chronic neuropathic pain following spinal cord injury. Glia 60, 1660\u20131670 (2012).","journal-title":"Glia"},{"key":"BFsrep38766_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3389\/fncel.2015.00495","volume":"9","author":"T Jeanson","year":"2016","unstructured":"Jeanson, T. et al. Antidepressants impact connexin 43 channel functions in astrocytes. Front Cell Neurosci. 9, 495 (2016).","journal-title":"Front Cell Neurosci"},{"key":"BFsrep38766_CR9","doi-asserted-by":"crossref","unstructured":"Ransom, B. & Giaume, C. Gap Junctions and hemichannels. Neuroglia (third edition), Oxford University Press (2012).","DOI":"10.1093\/med\/9780199794591.003.0024"},{"key":"BFsrep38766_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/BJ20051922","volume":"394","author":"DW Laird","year":"2006","unstructured":"Laird, D. W. Life cycle of connexins in health and disease. Biochem J. 394, 527\u2013543 (2006).","journal-title":"Biochem J."},{"key":"BFsrep38766_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0896-6273(91)90128-M","volume":"6","author":"C Giaume","year":"1991","unstructured":"Giaume, C. et al. Gap junctions in cultured astrocytes: single-channel currents and characterization of channel-forming protein. Neuron 6, 133\u2013143 (1991).","journal-title":"Neuron"},{"key":"BFsrep38766_CR12","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1523\/JNEUROSCI.5048-07.2008","volume":"28","author":"J Kang","year":"2008","unstructured":"Kang, J. et al. Connexin 43 hemichannels are permeable to ATP. J Neurosci. 28, 4702\u20134711 (2008).","journal-title":"J Neurosci."},{"key":"BFsrep38766_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/glia.22785","volume":"63","author":"V Abudara","year":"2015","unstructured":"Abudara, V. et al. Activated microglia impairs neuroglial interaction by opening Cx43 hemichannels in hippocampal astrocytes. Glia 63, 795\u2013811 (2015).","journal-title":"Glia"},{"key":"BFsrep38766_CR14","doi-asserted-by":"publisher","first-page":"13781","DOI":"10.1523\/JNEUROSCI.2042-07.2007","volume":"27","author":"MA Retamal","year":"2007","unstructured":"Retamal, M. A. et al. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci. 27, 13781\u201313792 (2007).","journal-title":"J Neurosci."},{"key":"BFsrep38766_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neulet.2006.12.043","volume":"415","author":"S Rana","year":"2007","unstructured":"Rana, S. & Dringen, R. Gap junction hemichannel-mediated release of glutathione from cultured rat astrocytes. Neurosci Lett. 415, 45\u201348 (2007).","journal-title":"Neurosci Lett."},{"key":"BFsrep38766_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fphar.2013.00088","volume":"4","author":"C Giaume","year":"2013","unstructured":"Giaume, C., Leybaert, L., Naus, C. C. & Saez, J. C. Connexin and pannexin hemichannels in brain glial cells: properties, pharmacology, and roles. Front Pharmacol. 4, 88 (2013).","journal-title":"Front Pharmacol"},{"key":"BFsrep38766_CR17","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1152\/jn.90722.2008","volume":"100","author":"PT Ohara","year":"2008","unstructured":"Ohara, P. T., Vit, J. P., Bhargava, A. & Jasmin, L. Evidence for a role of connexin 43 in trigeminal pain using RNA interference in vivo. J Neurophysiol. 100, 3064\u20133073 (2008).","journal-title":"J Neurophysiol."},{"key":"BFsrep38766_CR18","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.neuroscience.2009.09.038","volume":"164","author":"M Ledda","year":"2009","unstructured":"Ledda, M., Blum, E., De Palo, S. & Hanani, M. Augmentation in gap junction-mediated cell coupling in dorsal root ganglia following sciatic nerve neuritis in the mouse. Neuroscience 164, 1538\u20131545 (2009).","journal-title":"Neuroscience"},{"key":"BFsrep38766_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1017\/S1740925X10000025","volume":"6","author":"M Hanani","year":"2010","unstructured":"Hanani, M., Caspi, A. & Belzer, V. Peripheral inflammation augments gap junction-mediated coupling among satellite glial cells in mouse sympathetic ganglia. Neuron Glia Biol. 6, 85\u201389 (2010).","journal-title":"Neuron Glia Biol"},{"key":"BFsrep38766_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neures.2013.01.004","volume":"75","author":"SJ O\u2019Carroll","year":"2013","unstructured":"O\u2019Carroll, S. J., Gorrie, C. A., Velamoor, S., Green, C. R. & Nicholson, L. F. Connexin43 mimetic peptide is neuroprotective and improves function following spinal cord injury. Neurosci Res. 75, 256\u2013267 (2013).","journal-title":"Neurosci Res."},{"key":"BFsrep38766_CR21","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1523\/JNEUROSCI.20-05-01800.2000","volume":"20","author":"B Innocenti","year":"2000","unstructured":"Innocenti, B., Parpura, V. & Haydon, P. G. Imaging extracellular waves of glutamate during calcium signaling in cultured astrocytes. J Neurosci. 20, 1800\u20131808 (2000).","journal-title":"J Neurosci."},{"key":"BFsrep38766_CR22","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/369744a0","volume":"369","author":"V Parpura","year":"1994","unstructured":"Parpura, V. et al. Glutamate-mediated astrocyte-neuron signalling. Nature 369, 744\u2013747 (1994).","journal-title":"Nature"},{"key":"BFsrep38766_CR23","doi-asserted-by":"publisher","first-page":"21362","DOI":"10.1074\/jbc.M600504200","volume":"281","author":"H Takeuchi","year":"2006","unstructured":"Takeuchi, H. et al. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem. 281, 21362\u201321368 (2006).","journal-title":"J Biol Chem"},{"key":"BFsrep38766_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jpain.2012.11.002","volume":"14","author":"SY Yoon","year":"2013","unstructured":"Yoon, S. Y., Robinson, C. R., Zhang, H. & Dougherty, P. M. Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity. J Pain 14, 205\u2013214 (2013).","journal-title":"J Pain"},{"key":"BFsrep38766_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.expneurol.2010.03.002","volume":"224","author":"DH Roh","year":"2010","unstructured":"Roh, D. H. et al. Intrathecal injection of carbenoxolone, a gap junction decoupler, attenuates the induction of below-level neuropathic pain after spinal cord injury in rats. Exp Neurol. 224, 123\u2013132 (2010).","journal-title":"Exp Neurol."},{"key":"BFsrep38766_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/S1740925X10000098","volume":"6","author":"L Jasmin","year":"2010","unstructured":"Jasmin, L., Vit, J. P., Bhargava, A. & Ohara, P. T. Can satellite glial cells be therapeutic targets for pain control? Neuron Glia Biol. 6, 63\u201371 (2010).","journal-title":"Neuron Glia Biol"},{"key":"BFsrep38766_CR27","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/npp.2011.319","volume":"37","author":"JD Sun","year":"2012","unstructured":"Sun, J. D., Liu, Y., Yuan, Y. H., Li, J. & Chen, N. H. Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology 37, 1305\u20131320 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"BFsrep38766_CR28","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1111\/bph.12614","volume":"171","author":"N Morioka","year":"2014","unstructured":"Morioka, N. et al. Amitriptyline up-regulates connexin43-gap junction in rat cultured cortical astrocytes via activation of the p38 and c-Fos\/AP-1 signalling pathway. Br J Pharmacol. 171, 2854\u20132867 (2014).","journal-title":"Br J Pharmacol"},{"key":"BFsrep38766_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","volume":"33","author":"GJ Bennett","year":"1988","unstructured":"Bennett, G. J. & Xie, Y. K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33, 87\u2013107 (1988).","journal-title":"Pain"},{"key":"BFsrep38766_CR30","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1177\/1087057112452594","volume":"17","author":"C Picoli","year":"2012","unstructured":"Picoli, C. et al. Human Connexin Channel Specificity of Classical and New Gap Junction Inhibitors. J Biomol Screen 17, 1339\u20131347 (2012).","journal-title":"J Biomol Screen"},{"key":"BFsrep38766_CR31","doi-asserted-by":"publisher","first-page":"12364","DOI":"10.1073\/pnas.0402044101","volume":"101","author":"SJ Cruikshank","year":"2004","unstructured":"Cruikshank, S. J. et al. Potent block of Cx36 and Cx50 gap junction channels by mefloquine. Proc Natl Acad Sci. USA 101, 12364\u201312369 (2004).","journal-title":"Proc Natl Acad Sci. USA"},{"key":"BFsrep38766_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/(SICI)1098-1136(19990115)25:2<111::AID-GLIA2>3.0.CO;2-I","volume":"25","author":"P Kunzelmann","year":"1999","unstructured":"Kunzelmann, P. et al. Late onset and increasing expression of the gap junction protein connexin30 in adult murine brain and long-term cultured astrocytes. Glia 25, 111\u2013119 (1999).","journal-title":"Glia"},{"key":"BFsrep38766_CR33","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/glia.20698","volume":"56","author":"A Koulakoff","year":"2008","unstructured":"Koulakoff, A., Ezan, P. & Giaume, C. Neurons control the expression of connexin 30 and connexin 43 in mouse cortical astrocytes. Glia 56, 1299\u20131311 (2008).","journal-title":"Glia"},{"key":"BFsrep38766_CR34","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.euroneuro.2015.07.026","volume":"25","author":"S M\u2019Dahoma","year":"2015","unstructured":"M\u2019Dahoma, S. et al. Respective pharmacological features of neuropathic-like pain evoked by intrathecal BDNF versus sciatic nerve ligation in rats. Eur Neuropsychopharmacol. 25, 2118\u20132130 (2015).","journal-title":"Eur Neuropsychopharmacol."},{"key":"BFsrep38766_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2013.01.074","volume":"716","author":"F Viguier","year":"2013","unstructured":"Viguier, F., Michot, B., Hamon, M. & Bourgoin, S. Multiple roles of serotonin in pain control mechanisms-implications of 5-HT(7) and other 5-HT receptor types. Eur J Pharmacol. 716, 8\u201316 (2013).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep38766_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neulet.2014.01.042","volume":"563","author":"Q Xu","year":"2014","unstructured":"Xu, Q. et al. Intrathecal carbenoxolone inhibits neuropathic pain and spinal wide-dynamic range neuronal activity in rats after an L5 spinal nerve injury. Neurosci Lett. 563, 45\u201350 (2014).","journal-title":"Neurosci Lett."},{"key":"BFsrep38766_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1095\/biolreprod.113.110106","volume":"89","author":"H Diao","year":"2013","unstructured":"Diao, H. et al. Broad gap junction blocker carbenoxolone disrupts uterine preparation for embryo implantation in mice. Biol Reprod. 89, 31 (2013).","journal-title":"Biol Reprod."},{"key":"BFsrep38766_CR38","first-page":"224","volume":"41","author":"EC Ritchie","year":"2013","unstructured":"Ritchie, E. C., Block, J. & Nevin, R. L. Psychiatric side effects of mefloquine: applications to forensic psychiatry. J Am Psychiatry Law 41, 224\u2013235 (2013).","journal-title":"J Am Psychiatry Law"},{"key":"BFsrep38766_CR39","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/0306-3623(95)02082-9","volume":"27","author":"F Coudore","year":"1996","unstructured":"Coudore, F. et al. Pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites in streptozocin-induced diabetic rats. Gen Pharmacol. 27, 803\u2013807 (1996).","journal-title":"Gen Pharmacol."},{"key":"BFsrep38766_CR40","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/sj.bjp.0705721","volume":"141","author":"S Barraud de Lagerie","year":"2004","unstructured":"Barraud de Lagerie, S. et al. Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice. Br J Pharmacol 141, 1214\u20131222 (2004).","journal-title":"Br J Pharmacol"},{"key":"BFsrep38766_CR41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1096\/fj.05-4297fje","volume":"20","author":"W M\u00eame","year":"2006","unstructured":"M\u00eame, W. et al. Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid. FASEB J. 20, 494\u2013496 (2006).","journal-title":"FASEB J."},{"key":"BFsrep38766_CR42","doi-asserted-by":"publisher","first-page":"22659","DOI":"10.1073\/pnas.1013793107","volume":"107","author":"JM Garr\u00e9","year":"2010","unstructured":"Garr\u00e9, J. M. et al. FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels. Proc Natl Acad Sci. USA 107, 22659\u201322664 (2010).","journal-title":"Proc Natl Acad Sci. USA"},{"key":"BFsrep38766_CR43","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.bbrc.2015.07.105","volume":"464","author":"FF Zhang","year":"2015","unstructured":"Zhang, F. F., Morioka, N., Kitamura, T., Hisaoka-Nakashima, K. & Nakata, Y. Proinflammatory cytokines downregulate connexin 43-gap junctions via the ubiquitin-proteasome system in rat spinal astrocytes. Biochem Biophys Res Commun. 464, 1202\u20131208 (2015).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep38766_CR44","doi-asserted-by":"publisher","first-page":"8489","DOI":"10.1523\/JNEUROSCI.2552-08.2008","volume":"28","author":"A Latremoliere","year":"2008","unstructured":"Latremoliere, A. et al. Differential implication of proinflammatory cytokine interleukin-6 in the development of cephalic versus extracephalic neuropathic pain in rats. J Neurosci. 28, 8489\u20138501(2008).","journal-title":"J Neurosci."},{"key":"BFsrep38766_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/j.1552-4604.1995.tb04740.x","volume":"35","author":"A el-Yazigi","year":"1995","unstructured":"el-Yazigi, A., Chaleby, K., Gad, A. & Raines, D. A. Steady-state kinetics of fluoxetine and amitriptyline in patients treated with a combination of these drugs as compared with those treated with amitriptyline alone. J Clin Pharmacol. 35, 17\u201321 (1995).","journal-title":"J Clin Pharmacol"},{"key":"BFsrep38766_CR46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1475-2875-10-150","volume":"10","author":"GS Dow","year":"2011","unstructured":"Dow, G. S. et al. Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice. Malaria J. 10, 150 (2011).","journal-title":"Malaria J"},{"key":"BFsrep38766_CR47","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/FBP.0b013e328345ca4e","volume":"22","author":"JA Mico","year":"2011","unstructured":"Mico, J. A. et al. Effects of milnacipran, duloxetine and indomethacin, in polyarthritic rats using the Randall-Selitto model. Behav Pharmacol. 22, 599\u2013606 (2011).","journal-title":"Behav Pharmacol."},{"key":"BFsrep38766_CR48","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/sj.bjp.0707238","volume":"151","author":"AJ Thompson","year":"2007","unstructured":"Thompson, A. J., Lochner, M. & Lummis, S. C. The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptors. Br J Pharmacol. 151, 666\u2013677 (2007).","journal-title":"Br J Pharmacol"},{"key":"BFsrep38766_CR49","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00213-014-3446-0","volume":"231","author":"A Janowsky","year":"2014","unstructured":"Janowsky, A. et al. Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro. Psychopharmacology (Berl) 231, 2771\u20132783 (2014).","journal-title":"Psychopharmacology (Berl)"},{"key":"BFsrep38766_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0304-3959(93)90100-4","volume":"54","author":"TJ Maves","year":"1993","unstructured":"Maves, T. J., Pechman, P. S., Gebhart, G. F. & Meller, S. T. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain 54, 57\u201369 (1993).","journal-title":"Pain"},{"key":"BFsrep38766_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1744-8069-10-47","volume":"10","author":"E Rojewska","year":"2014","unstructured":"Rojewska, E., Korostynski, M., Przewlocki, R., Przewlocka, B. & Mika, J. Expression profiling of genes modulated by minocyline in a rat model of neuropathic pain. Mol Pain 10, 47 (2014).","journal-title":"Mol Pain"},{"key":"BFsrep38766_CR52","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1523\/JNEUROSCI.4495-14.2015","volume":"35","author":"A Ford","year":"2015","unstructured":"Ford, A. et al. Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain. J Neurosci 35, 6057\u20136067 (2015).","journal-title":"J Neurosci"},{"key":"BFsrep38766_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2016.02.046","volume":"776","author":"HSM Farghaly","year":"2016","unstructured":"Farghaly, H. S. M., Mahmoud, A. M. & Abdel-Sater, K. A. Effect of dexmedetomidine and cold stress in a rat model of neuropathic pain: Role of interleukin-6 and tumor necrosis factor-\u221d. Eur J Pharmacol 776, 139\u2013145 (2016).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep38766_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ejphar.2016.09.019","volume":"791","author":"M Zychowska","year":"2016","unstructured":"Zychowska, M. et al. Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain. Eur J Pharmacol 791, 377\u2013388 (2016).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep38766_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejphar.2011.01.022","volume":"655","author":"E Berrocoso","year":"2011","unstructured":"Berrocoso, E. et al. Evaluation of milnacipran, in comparison with amitriptyline, on cold and mechanical allodynia in a rat model of neuropathic pain. Eur J Pharmacol. 655, 46\u201351 (2011).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep38766_CR56","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2003.12.048","volume":"357","author":"B Sung","year":"2004","unstructured":"Sung, B. & Wang, G. K. Peripherally administered amitriptyline derivatives have differential anti-allodynic effects in a rat model of neuropathic pain. Neurosci Lett. 357, 115\u2013118 (2004).","journal-title":"Neurosci Lett."},{"key":"BFsrep38766_CR57","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0014-2999(01)01276-6","volume":"430","author":"MJ Esser","year":"2001","unstructured":"Esser, M. J., Chase, T., Allen, G. V. & Sawynok, J. Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions. Eur J Pharmacol. 430, 211\u2013218 (2001).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep38766_CR58","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","volume":"53","author":"D Le Bars","year":"2001","unstructured":"Le Bars, D., Gozariu, M. & Cadden, S. W. Animal models of nociception. Pharmacol Rev. 53, 597\u2013652 (2001).","journal-title":"Pharmacol Rev"},{"key":"BFsrep38766_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/S146114570500547X","volume":"9","author":"E Obuchowicz","year":"2006","unstructured":"Obuchowicz, E. et al. Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. Int J Neuropsychopharmacol. 9, 27\u201335 (2006).","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFsrep38766_CR60","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.neuropharm.2008.06.045","volume":"55","author":"J Hwang","year":"2008","unstructured":"Hwang, J. et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 55, 826\u2013834 (2008).","journal-title":"Neuropharmacology"},{"key":"BFsrep38766_CR61","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ejphar.2011.05.053","volume":"667","author":"H Sadeghi","year":"2011","unstructured":"Sadeghi, H., Hajhashemi, V., Minaiyan, M., Movahedian, A. & Talebi, A. A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats. Eur J Pharmacol. 667, 396\u2013401 (2011).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep38766_CR62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejphar.2013.01.072","volume":"716","author":"J Mika","year":"2013","unstructured":"Mika, J., Zychowska, M., Popiolek-Barczyk, K., Rojewska, E. & Przewlocka, B. Importance of glial activation in neuropathic pain. Eur J Pharmacol. 716, 106\u2013119 (2013).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep38766_CR63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann, M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109\u2013110 (1983).","journal-title":"Pain"},{"key":"BFsrep38766_CR64","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2174\/187152711794653869","volume":"10","author":"JA Orellana","year":"2011","unstructured":"Orellana, J. A. et al. Hemichannels in the neurovascular unit and white matter under normal and inflamed conditions. CNS Neurol Disord Drug Targets 10, 404\u2013414 (2011).","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"BFsrep38766_CR65","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3, 1101\u20131108 (2008).","journal-title":"Nat Protoc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep38766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38766","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:50:35Z","timestamp":1749808235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep38766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,12]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep38766"],"URL":"https:\/\/doi.org\/10.1038\/srep38766","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,12]]},"assertion":[{"value":"1 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by the Commissariat \u00e0 l\u2019Energie Atomique and Theranexus Company. TJ, AD, CP, FM and MC are employees of Theranexus. The other authors declare no potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38766"}}